2007 ICD-9-CM Procedure 99.28 Injection or infusion of biological response modifier [brm] as an antineoplastic agent 99.28 is a specific code that can be used to specify a procedure 99.28 contains 25 index entries View the full Volume 3 99.* hierarchy 99.28 also known as: Immunotherapy, antineoplastic Infusion of cintredekin besudotox Interleukin therapy Low-dose interleukin-2 (IL-2) therapy Tumor vaccine 99.28 excludes: high-dose infusion interleukin-2 [IL-2] (00.15) Index entries containing 99.28: Immunotherapy, antineoplastic 99.28 C-Parvum 99.28 Interferon 99.28 Interleukin-2 (low-dose) 99.28 high-dose 00.15 Levamisole 99.28 Proleukin (low-dose) 99.28 high-dose 00.15 Thymosin 99.28 Infusion (intra-arterial) (intravenous) antineoplastic agent (chemotherapeutic) 99.25 biological response modifier [BRM] 99.28 cintredekin besudotox 99.28 low-dose interleukin-2 99.28 biological response modifier [BRM], antineoplastic agent 99.28 cintredekin besudotox 99.28 high-dose interleukin-2 00.15 low-dose interleukin-2 99.28 cintredekin besudotox 99.28 Proleukin (low-dose) 99.28 high-dose 00.15 vaccine tumor 99.28 Injection (into) (hypodermically) (intramuscularly) (intravenously) (acting locally or systemically) antineoplastic agent (chemotherapeutic) NEC 99.25 biological response modifier [BRM] 99.28 cintredekin besudotox 99.28 low-dose interleukin-2 99.28 biological response modifier [BRM], antineoplastic agent 99.28 cintredekin besudotox 99.28 high-dose interleukin-2 00.15 low-dose interleukin-2 99.28 cintredekin besudotox 99.28 vaccine tumor 99.28 Vaccination (prophylactic) (against) 99.59 tumor 99.28